chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Discharge Provider:  Primary Care Provider:  Admission Date: 6/28/2022 Discharge Date: Jul 29, 2022  PRESENTING PROBLEM: Hypoxic Bilateral pulmonary embolism Pneumonia due to COVID-19 virus Pulmonary embolism and infarction Hypotension Acute respiratory failure with hypoxia   HOSPITAL COURSE: Patient is a  63 y.o. female with past medical history of mantle cell lymphoma status post chemo and stem cell transplant, ulcerative colitis on mesalamine, latent TB, hemochromatosis, and primary sclerosing cholangitis.  Patient presented to the emergency department secondary to dizziness and syncopal episode. In Emergency department patient was hypoxic and is requiring 4 L of supplemental oxygen.  Temperature was 38° and she was initially tachycardic at 1:41 a.m..  Lab significant for phosphorus 1.9, alk-phos 142, BNP 355, procalcitonin 0.16, lactic acid 1.2-> 0.7, troponin 42-> 45.  COVID was positive.  Blood cultures x2 were drawn.  Urinalysis was without evidence of infection.  EKG showed sinus tachycardia with lateral T-wave inversion and nonspecific ST changes.  CTA thorax showed significant bilateral pulmonary emboli with right heart strain and moderate ground-glass and reticular opacities which favor pulmonary infarct.  Bilateral lower extremity ultrasound showed acute occlusive superficial venous thrombosis in the left greater saphenous vein from the knee to the common femoral vein and tiny acute nonocclusive DVT in the left common femoral vein.  Bilateral upper extremity ultrasounds were without evidence of DVT.  A PERT call was performed and case was discussed with pulmonology and IR who felt patient was a candidate for mechanical thrombectomy.  Recommended she be initiated on heparin drip.     Given overall clot burden patient was taken down for mechanical thrombectomy.  Postprocedure patient became hypotensive.  Patient was transferred to intensive care unit for close monitoring.  Thought to be due to hematoma at the access site so heparin was had.  CT angiogram of abdomen and pelvis are obtained which was negative for acute GI bleed.  1 unit of blood was given.  Blood pressure was improved.As CT was negative on groin site was stable, heparin was restarted and hemoglobin remained stable. She was subsequent transitioned to Eliquis   Her stay was prolonged due to continued high levels of oxygen requirements with activity. She was started on IV Methylprednisolone as per pulmonology given COVID-19.  Had bronchoscopy with pulmonology 7/20, pulmonology recommended gradually tapering steroids, started on Bactrim for PJP prophylaxis.  Developed bilateral small pneumothorax, pneumomediastinum and subcutaneous emphysema post bronchoscopy, which was closely monitor with daily x-ray, CT surgery and pulmonology recommended supportive care.  Evaluated by Pulmonary rehab, oxygen. requirement upon discharge was 4 liters at baseline and 6 liters with exertion with oxygen pendant. She was discharged home with home care.
Severe Headache, Chills , Body Aches, Fever of 98.5
Pt received full course of Varicella >100 pustules after vaccine given by previous provider 1/9/97. Pt diagnosed 11/30/99.
This is a verbatim narrative as reported on web site, accessed on 28 July 2011. According to the web site these reports were FDA VAERS. "FLUMIST problem was reported on Mar 05, 2007. Female patient, 48 years of age, was vaccinated with FLUMIST on Feb 03, 2007. "Ear feeling clogged, hearing loss, constant sinus drainage, sore throat. 4 visit to doctor."...None. Patient recovered."
patient had a little soreness at injection site when administered.  On September 30, 2019, patient reported that she still had some soreness at the injection site when no movement of the arm.  States that there is no redness or irritation at the injection site.
Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration on 15Apr2021 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included diverticulosis. The patient had known allergies to surgical adhesives. The patient received unknown concomitant medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER6955) via an unspecified route of administration on 22Mar2021 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. On an unknown date in Apr2021 the patient experienced tinnitus. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures, which included COVID-19 virus test (nasal swab) on 20Jul2021 and tested negative. The clinical outcome of the event tinnitus was not recovered at the time of this report.
Myocarditis. Developed chest pain, without fever or other ill symptoms, 2 days after vaccine. Found to have elevated troponin, BNP, D dimer.  Admitted to hospital for 3 days. Treated with 3 days of steroids in hospital, on ASA until f/u Cardiology.
hours after the 2nd vaccine was given that night 1/20/2021 she  noticed puncture site of administered vaccine was too high Day1, after 24 hours,  late morning felt malaise, lethargic , all muscle achy but left shoulders was painful  to move, ALL active full range of motion was difficult without pain, No history of  past injury current or remote past, physical exam (pt asked over phone- no redness  no skin changes, no masses, no lymphadenopathy. Saw her PCP diagnosed vaccine  related adverse most likely intra -arthricular injection technique - Referred to  Physical therapy and Orthopedics
Felt that my heart was racing , I also felt light headed. I was sent to the ER to be monitored for 4 hours.. they checked my vital and sent me home after everything was clear .
This spontaneous report was received from a consumer via Pfizer refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with PNEUMOVAX 23 (dose, units, frequency, lot# and expiration date unknown) and PREVNAR 13 (dose, units, frequency, lot# and expiration date unknown). On an unknown date, the patient still got pneumonia and was hospitalized. Outcome of the event was unknown. The reporter's causality assessment was not provided.
High fever 2-3 days after receiving HPV #1 for 2-3 days; with vomiting for 1 day and Rt sided stomach ache for 1 day, mother took her to ER; seen at medical center; came for checkup today and the clinic was informed today only (4-30-08).
Flushed, reddened cheeks, itchy, tingling  eyes, slight swelling, tingling lips, slight swelling  20 minutes after injection Untreated symptoms significantly reduced after 3-4 hours except itchy, watery eyes Itchy, watery eyes is ongoing a week after the injection, now being treated with Lotemax steroid eye drops
extreme fatigue, migraine, nausea, 102 degree fever, chills, night sweats, body aches. fatigue and head ache began about 3 hours after the vaccine was administered. I woke up in the middle of the night that night with the rest of the symptoms which last for about 20 hours. I also had a large bump and red, itchy rash at the injection site which lasted 6 days.
Three hours post vaccine pt's right leg became swollen, red and warm to the touch. Mother was advised to apply warm compresses to site and monitor temperature.
Next day after vaccination redness and swelling to injection site. Later that day and still today redness, swelling and now itching.
fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-May-2021, Body temperature: 102 (High) 102. On an unknown date, Body temperature: 101.4 (High) 101.4.         No concomitant medications were reported. No treatment medications were reported.  Action taken with mRNA-1273 in response to the event was not applicable.
0945-vaccine given. 1030- symptoms developed, scratchy throat, scratchy roof of mouth, change in voice tone. 1045- BENADRYL 25mg po, 1110-sent to urgent care given BENADRYL IM, KENALOG IM, and Rx for MEDROL dose pack.
On 03/03/2023, I had a sore throat and what felt like would maybe become a head cold or allergies. I figured it would go away through the day. I woke up on 03/04/2023, feeling even worse. I tested for COVID-19 on 03/03/2023 and it was negative. I tested again on 03/04/2023 and it was positive, along with my husband and daughter. We all isolated. I had fever, a cough, bronchial congestion. My doctor recommended that I use an albuterol inhaler and take Ibuprofen every six hours. That night, I started to feel my bronchial close. I called my doctor who suggested I take Paxlovid. The Paxlovid almost immediately resolved the congestion in my lungs, but the Paxlovid is such a strong medication, I felt bad from it. On 03/05/2023, I got a sever ocular migraine with a visual aura which I've never had before. Colors looked brighter than they actually are. I started seeing geometric type shapes in a laser type like. It was the strangest experience I have had, and it was startling to me. On the night of 03/06/2023, I had even more severe visual migraine issues that woke me out of sleep. I called my doctor on 03/07/2023 to describe my symptoms. I had checked myself for stroke like symptoms and did not have anything concerning of that. I saw my doctor the next morning. They felt that I was having a reaction to the Paxlovid in combination with a severe migraine. They said it was common in their experience for people with a history of migraines and COVID-19. They took me off of the Paxlovid a day and half early. I stopped the next day, since I had already taken my doses. Once I stopped the Paxlovid, I felt better. They decided that my symptoms had improved enough that it would be better for me to stop taking the Paxlovid. I did not have a recurrence of COVID-19. While I had COVID-19, my right knee became very inflamed and swollen and painful. I went back to the doctor's office and explained that I had a history of rheumatoid arthritis, but it was in remission. I had just had my blood work done and the rheumatoid factor was nil. There was concern that it was a immune reaction. She prescribed Prednisone, which helped with the swelling, but it did not go away completely, and I was still in pain. I messaged the doctor who suggested that I get a corticosteroid shot to the knee and physical therapy. He advised that I not walk that much, and I kept my steps below 3500 a day. I didn't feel like I over did it, but I have a child and I may have. While standing, I heard a loud snap and felt extreme pain in my right knee. I knew something was wrong, so I returned to my doctor the next morning, who diagnosed me with a torn or snapped MCL. He advised I wear a brace on my knee and more physical therapy. The brace has helped, along with rest, and I have a physical therapy appointment soon. If that doesn't help, he referred me to an orthopedic surgeon.
This spontaneous case was initially received on 03-Nov-2015. The case report was received from a Health Professional and concerns a 26 years old male. Weight: 240 pounds, Height: 74 inches. For concomitant medication and therapy dates refer to the appropriate report section. The patient received AFLURIA on 09-Oct-2015 - 09-Oct-2015, Batch no: T51608, Route of administration: Intramuscular, Dose: 0.5 ml. No additional drugs suspected. On 09-Oct-2015, the patient received an IM dose of expired AFLURIA. For relevant test results see appropriate report section. Reporter's assessment.
7/16 Presents to HD with redness at of swelling on (R) mid upper arm. 16.5 x 11cm reddened area encircling 6.25 x 7 cm raised area cool pack applied to arm. Advised client's father to notify PCP. Client afebrile. 7/19 decreased s/s.
Patient complained to have sore arm for more than 4 months now. Normally, the soreness only last a few days.
CLIENT RECEIVED PFIZER COVID VACCINE 2ND DOSE TOO SOON. ONLY 10 DAYS BETWEEN 1ST DOSE AND 2ND DOSE WHEN THE RECOMMENDATION IS TO WAIT 21 DAYS BETWEEN DOSES.
Loss of appetite, fatigue, nausea, fluid collection in elbow, tender lymph nodes in left side neck.
47 YEAR OLD MALE THOUGHT HE WAS HAVING AN ALLERGIC REACTION. ONSITE EMS AND PHYSICIAN RESPONDED.  BP 142/80 HR 98  PATIENT REFUSED ADDITIONAL EVALUATION AND CARE. RELEASED AGAINST MEDICAL ADVICE.
persistent vomiting for several hours resulting in emergency room visit.  Treated with Zofran, Ativan and IV fluids.  CT Scan needed to rule out intestinal obstruction as patient has Crohn's colitis.
This spontaneous report was received from a nurse refers to 5 patients of unknown age and gender. No concurrent condition or medical history was reported. On 17-FEB-2016, the patients were vaccinated with improperly stored doses of VAQTA (lot # L039569, exp. 15-MAR-2017, dose and route of administration not provided). No concomitant therapy was reported. No adverse effects were reported. The outcome of the event was unknown. No product quality issue was involved. This is one of the two reports from the same reporter. Additional information has been requested.
10/31/22 Cystitis day 5. Urinalysis showed no blood or bacteria this time.  11/16/21 - Previous Pfizer cystitis day 6  (without any anti-inflammatory pre-med) booster had hematuria 2/10/21 - Moderna left pleurisy with pleural effusion  day #5
Irregular menstrual cycle; Heavier bleeding than normal; Debilitating cramps; This is a spontaneous report received from a contactable consumer reported herself (Patient).  A 29-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection) via an unspecified route of administration at left arm on 11Jun2021 11:45 (at the age of 29-year-old) (Batch/Lot number: Not provided) as single dose for COVID-19 immunisation. Medical history included allergies, asthma, cats allergy, nut allergy, latex allergy, pollen allergy, celery allergy and apples allergy. Concomitant medication included loratadine (CLARITINE). The patient other medications in two weeks included allergy shots. The patient previously took ciprofloxacin and experienced known allergies. Patient was not pregnant at the time vaccination. Patient did not receive any other vaccines within the 4 weeks. Patient do not have COIVD prior to vaccination. The patient experienced Irregular menstrual cycle. Spotting within 48 hours of vaccine (taken before ovulation). Period two weeks earlier than normal and was lasting much longer. Heavier bleeding than normal. Debilitating cramps on 12Jun2021 at 12:00 AM. Patient did not receive any treatment for the events. Outcome of events was not recovered.  Follow-up attempts are completed. No further information is expected; information about lot/batch number cannot be obtained.
Pt developed hives to entire body including face and had some shortness of breath so went to urgent care. Was given steroid injection and oral steroids and symptoms resolved. Hives developed approx 36 hours after vaccine.
Back pain; muscle spasms; barely walked; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administration date 19Mar2021 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: BACK PAIN (non-serious) with onset 20Mar2021, outcome "unknown", described as "Back pain"; MUSCLE SPASMS (non-serious) with onset 20Mar2021, outcome "unknown", described as "muscle spasms"; GAIT DISTURBANCE (non-serious) with onset 20Mar2021, outcome "unknown", described as "barely walked".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
A few days after my first dose of the Pfizer vaccine, I began having a high pitch ringing sound in my ear.  I began unplugging appliances in my home trying to figure out what was causing it.  I finally went outside and realized the sound was in my head.  It wasn't as noticeable  when there were other sounds going on in my background.  After the second shot, I began to have a terrible earache on the side my injection was given and now my ears are ringing even louder.  I am scheduling an appointment with an ENT this week.  My gut told me not to get this vaccine.  I wish I would have listen to it.  I am beyond sad because everything I've read so far is that it doesn't go away.  Shame on you all for pushing this so fast on to the public.
Runny nose; Congestion; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose) and NASAL CONGESTION (Congestion) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jun-2021, the patient experienced RHINORRHOEA (Runny nose) and NASAL CONGESTION (Congestion). The patient was treated with FEXOFENADINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE (ALLEGRA D) at an unspecified dose and frequency. At the time of the report, RHINORRHOEA (Runny nose) and NASAL CONGESTION (Congestion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 69-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 29Sep2022 as dose 5 (booster), single (Lot number: GJ2524) at the age of 69 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hashimotos" (unspecified if ongoing); "Injected iodine allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Benadryl, reaction(s): "Anxiety". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Dec2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 with paxlovid from 19Dec2022 to 24Dec2022.  No follow-up attempts are possible. No further information is expected.
Swelling under left armpit, size of a golf ball.  Rash all over both legs and neck
Information has been received from a nurse concerning a female who in August 2007 was vaccinated with a first dose of Gardasil.  The patient may have been vaccinated with another unspecified vaccine in the opposite arm.  Subsequently the patient fainted.  Patient was monitored in the office and recovered.  Additional information has been requested.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 45-year-old male patient received BNT162b2 (BNT162B2), on 04Jan2021 as dose 1, single (Lot number: EL1284), in left arm, on 25Jan2021 as dose 2, single (Lot number: EL9262), in left arm, on 27Sep2021 as dose 3 (booster), single (Lot number: FF8893), in left arm and on 02Apr2022 as dose 4 (booster), single (Lot number: FK9893) at the age of 44 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Past drug history included: Ibuprofen, reaction(s): "known allergies: Ibuprofen", notes: known allergies: Ibuprofen.  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (27Jul2022) Negative, notes: after testing negative on day 8; (30Jul2022) Positive, notes: Retested positive on day 11. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: The patient had received vaccine. Had not received other medication in 2 weeks. Reported anti viral details regarding product COVID 19 Treatment, brand name was reported as plaxovid, treatment started on 19Jul2022, and treatment stopped on 123ul2022, lot number reported was GC9416. The treatment received for the indication COVID-19. The adverse event reported that retested positive on day 11 after testing negative on day 8 on 29Jul2022. Used of Paxlovid as recommended. The event was not recovered. Therapeutic measures was not taken for the event.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on available information, the causal association  between the events Vaccination failure, Covid-19 and suspect drug BNT162b2 cannot be excluded completely.
Had started with period/ had period 17 days ago; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 26Apr2021 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sertraline hydrochloride (ZOLOFT), taken for an unknown indication from an unknown date and unknown if ongoing. On an unknown date in Apr2021, the patient woke up to find that her period had started. The patient reported that she just had her period 17 days back and her periods were very regular so it was very unusual. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event period had started unusually was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Right posterior upper arm with 5x3 cm area of warmth, 1/2 cm area of induration, mild edema non tender - will start Bactrim.